Innovation in a First-In-Human Trial

Innovation in a First-In-Human Trial

With over 70,000 annual deaths, fentanyl overdose is the leading cause of death for Americans aged 18-45. In collaboration with Cessation Therapeutics, Dr. Vince Clinical Research (DVCR) led a First-in-Human trial to test a breakthrough anti-fentanyl antibody....